Følg
Fang Shen
Fang Shen
Immunome
Verificeret mail på immunome.com
Titel
Citeret af
Citeret af
År
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
SA Khader, GK Bell, JE Pearl, JJ Fountain, J Rangel-Moreno, GE Cilley, ...
Nature immunology 8 (4), 369-377, 2007
17292007
Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis
HR Conti, F Shen, N Nayyar, E Stocum, JN Sun, MJ Lindemann, AW Ho, ...
Journal of Experimental Medicine 206 (2), 299-311, 2009
11612009
Structure–function relationships in the IL-17 receptor: implications for signal transduction and therapy
F Shen, SL Gaffen
Cytokine 41 (2), 92-104, 2008
3742008
Identification of common transcriptional regulatory elements in interleukin-17 target genes
F Shen, Z Hu, J Goswami, SL Gaffen
Journal of Biological Chemistry 281 (34), 24138-24148, 2006
3612006
Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17-and TNF-α-induced genes in bone cells
F Shen, MJ Ruddy, P Plamondon, SL Gaffen
Journal of leukocyte biology 77 (3), 388-399, 2005
3582005
Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment
MJ Ruddy, F Shen, JB Smith, A Sharma, SL Gaffen
Journal of leukocyte biology 76 (1), 135-144, 2004
2592004
Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression
A Maitra, F Shen, W Hanel, K Mossman, J Tocker, D Swart, SL Gaffen
Proceedings of the National Academy of Sciences 104 (18), 7506-7511, 2007
2202007
The IL‐17 cytokine family
SL Gaffen, JM Kramer, JY Jeffrey, F Shen
Vitamins & hormones 74, 255-282, 2006
2152006
The IL‐17 pathway as a major therapeutic target in autoimmune diseases
Y Hu, F Shen, NK Crellin, W Ouyang
Annals of the New York Academy of Sciences 1217 (1), 60-76, 2011
1822011
IL-17 receptor signaling inhibits C/EBPβ by sequential phosphorylation of the regulatory 2 domain
F Shen, N Li, P Gade, DV Kalvakolanu, T Weibley, B Doble, JR Woodgett, ...
Science signaling 2 (59), ra8-ra8, 2009
1622009
IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail
AW Ho, F Shen, HR Conti, N Patel, EE Childs, AC Peterson, ...
The Journal of Immunology 185 (2), 1063-1070, 2010
1442010
Cutting edge: evidence for ligand-independent multimerization of the IL-17 receptor
JM Kramer, L Yi, F Shen, A Maitra, X Jiao, T Jin, SL Gaffen
The Journal of Immunology 176 (2), 711-715, 2006
1412006
Differential role for c-Rel and C/EBPβ/δ in TLR-mediated induction of proinflammatory cytokines
YC Lu, I Kim, E Lye, F Shen, N Suzuki, S Suzuki, S Gerondakis, S Akira, ...
The Journal of Immunology 182 (11), 7212-7221, 2009
1382009
Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor
JM Kramer, W Hanel, F Shen, N Isik, JP Malone, A Maitra, W Sigurdson, ...
The Journal of Immunology 179 (10), 6379-6383, 2007
702007
Combined Blockade of TNF-α and IL-17A Alleviates Progression of Collagen-Induced Arthritis without Causing Serious Infections in Mice
GSLOT Shen F, Verma AH, Volk A, Jones B, Coleman BM, Loza MJ, Malaviya R ...
J Immunol 202 (7), 2017, 2019
352019
Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease
T Lu, PJ Connolly, U Philippar, W Sun, MD Cummings, K Barbay, L Gys, ...
Bioorganic & Medicinal Chemistry Letters 29 (23), 126743, 2019
132019
Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A
S Zheng, F Shen, B Jones, D Fink, B Geist, I Nnane, Z Zhou, J Hall, ...
MAbs 12 (1), 1770018, 2020
82020
Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety, and Tolerability of JNJ-61178104, a Novel Tumor Necrosis Factor-Alpha and Interleukin-17A Bispecific Antibody, in …
XZ Akpalu DE, Frederick B, Nnane IP, Yao Z, Shen F, Ort T, Fink D, Dogmanits ...
J Clin Pharmacol, 2019
72019
Bispecific Anti-TNF-Alpha/IL17A Antibodies and Anti-TNF-Alpha Antibodies and Methods of Their Use
M Chiu, J Nemeth-Seay, T Ort, F Shen
US Patent App. 15/417,560, 2017
52017
Pre-ligand assembly domain of the IL-17 receptor
SL Gaffen, F Shen, W Hanel, J Kramer, JP Malone, M Wittekind, R Paxton
US Patent 8,460,647, 2013
42013
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20